The comparison of insulin and uric acid levels in adolescents with and without metabolic syndrome

Abstract

BACKGROUND and AIM: The prevalence of metabolic syndrome (MS) increased in recent years in both adolescents and children groups. The aim of the study is evaluating the relationship between insulin and uric acid (UA) level in MS in adolescents

MATERIALS and METHODS: we studied 120 adolescence aged 10 to 19 in two groups: control group without metabolic syndrome and case group with metabolic syndrome. The Criteria of ATP III was considered as a diagnosis factor for metabolic syndrome.

DISCUSSION: Various studies have been conducted in various populations to evaluate the relationship between UA level and MS in adolescents. Abdominal obesity, low HDL, hypertriglyceridemia and hypertension are associated with high UA level. In their analysis, the MS OR in UA level≤4.9, 4.9-5.8 and≥5.8 mg/dl was 1, 2.53 and 9.03, respectively, which were higher than our findings in current study. Hyperinsulinemia caused by insulin resistance is one of the complications associated with MS, which puts individuals at risk of diabetes and cardiovascular events.

RESULTS: Uric acid level in the Case group was significantly higher than the control group (p = 0.0001, 43.8±1.4 vs. 4.1±1 mg/dl, respectively). Insulin level was significantly higher in the case group in compare to the control group (p = 0.008, 9.8±5.3 vs. 12.2±6 mU/ml, respectively).

CONCLUSION: The findings of this case-control study showed that adolescents with metabolic syndrome have a higher uric acid and insulin level in compare to normal subjects. We hypothesis that increase in serum insulin and uric acid level can be a risk factor in the development of metabolic syndrome.

Key words： metabolic syndrome; uric acid; insulin; adolescents

Acknowledgment

This study was supported by Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Compliance with ethics guidelines

The authors declare no conflict of interest. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

1 Anderson J L, May H T, Horne B D, Bair T L, Hall N L, Carlquist J F, Lappé D L, Muhlestein J B, and the Intermountain Heart Collaborative (IHC) Study Group (2010). Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol, 106(7): 963–968

PMID

2 Balkau B, Charles M A, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin J S, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B, and the European Group For The Study Of Insulin Resistance (EGIR) (2002). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab, 28(5): 364–376

PMID

3 Cardoso A S, Gonzaga N C, Medeiros C C, Carvalho D F (2013). Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. J Pediatr (Rio J), 89(4): 412–418

PMID

4 Chen J H, Chuang S Y, Chen H J, Yeh W T, Pan W H (2009). Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum, 61(2): 225–232

PMID

5 Currie G, Delles C (2013). Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis, 7: 13–24

PMID

6 de Ferranti S D, Gauvreau K, Ludwig D S, Neufeld E J, Newburger J W, Rifai N (2004). Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation, 110(16): 2494–2497

PMID

7 DeBoer M D, Dong L, Gurka M J ( 2011). Racial/ethnic and sex differences in the ability of metabolic syndrome criteria to predict elevations in fasting insulin levels in adolescents. The Journal of pediatrics. 159(6):975–81. e3

8 Ford E S, Li C, Cook S, Choi H K (2007). Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation, 115(19): 2526–2532

PMID

9 Haffner S M (2006). The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol, 97(2 2A): 3A–11A

PMID

10 Han T S, Lean M E (2016). A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis, 5: 2048004016633371

PMID

11 Hanley A J, Karter A J, Williams K, Festa A, D’Agostino R B Jr, Wagenknecht L E, Haffner S M (2005). Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation, 112(24): 3713–3721

PMID

12 Haybar H, Jalali M, Zayeri Z (2018). What genetic tell us about cardiovascular disease in diabetic patients. Cardiovasc Hematol Disord Drug Targets, 18(2): 147–152

13 Haybar H, Zayeri Z D (2017). The value of using polymorphisms in anti-platelet therapy. Frontiers in Biology., 12(5): 349–356

14 Kassi E, Pervanidou P, Kaltsas G, Chrousos G (2011). Metabolic syndrome: definitions and controversies. BMC Med, 9(1): 48

PMID

15 Kaur J (2014). A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014: 943162

16 Kelly C T, Mansoor J, Dohm G L, Chapman W H 3rd, Pender J R 4th, Pories W J (2014). Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think. Surgery, 156(2): 405–411

PMID

17 Li C, Hsieh M C, Chang S J (2013). Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol, 25(2): 210–216

PMID

18 Li Q, Zhou Y, Dong K, Wang A, Yang X, Zhang C, Zhu Y, Wu S, Zhao X (2015). The association between serum uric acid levels and the prevalence of vulnerable atherosclerotic carotid plaque: a cross-sectional study. Sci Rep, 5(1): 10003

PMID

19 Li X, Song P, Li J, Wang P, Li G (2015). Relationship between hyperuricemia and dietary risk factors in Chinese adults: a cross-sectional study. Rheumatol Int, 35(12): 2079–2089

PMID

20 Lteif A A, Han K, Mather K J (2005). Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation, 112(1): 32–38

PMID

21 MacPherson M, de Groh M, Loukine L, Prud’homme D, Dubois L ( 2016). Prevalence of metabolic syndrome and its risk factors in Canadian children and adolescents: Canadian Health Measures Survey Cycle 1 (2007–2009) and Cycle 2 (2009–2011). Health Promot Chronic Dis Prev Can, 36(2):32–40

22 Nejatinamini S, Ataie-Jafari A, Qorbani M, Nikoohemat S, Kelishadi R, Asayesh H, Hosseini S (2015). Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord, 14(1): 70

PMID

23 Orchard T J, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S, and the Diabetes Prevention Program Research Group (2005). The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med, 142(8): 611–619

PMID

24 Perez-Ruiz F, Becker M (2015) .Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease. Curr Med Res Opin, 31 Suppl 2: 9–14

25 Ritchie S A, Connell J M (2007). The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis, 17(4): 319–326

PMID

26 Rutter M K, Meigs J B, Sullivan L M, D’Agostino R B Sr, Wilson P W (2005). Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes, 54(11): 3252–3257

PMID

27 Shahbazian H, Absalan A, Jalali M T, Mastipour F, Kaydani G A, Zayeri Z D(2018). Comparison of zinc, copper, selenium, magnesium, aluminium and lead blood concentrations in end-stage renal disease patients and healthy volunteers in Ahvaz, southwest of Iran. Russian Open Medical Journal, 7(1):Article CID e0105

28 Sun H L, Pei D, Lue K H, Chen Y L (2015). Uric acid levels can predict metabolic syndrome and hypertension in adolescents: a 10-year longitudinal study. PLoS One, 10(11): e0143786

PMID

29 Sung K C C, Seo M H H, Rhee E J J, Wilson A M (2011). Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc Diabetol, 10(1): 108

PMID